Evidence map›Paper›PMID 33856084›Full record

ArticleThe oncologist2021

COVID-19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population- and Registry-Based Study.

Eduard Vrdoljak, Melita Perić Balja, Zlatko Marušić, Manuela Avirović, Valerija Blažičević, Čedna Tomasović, Dora Čerina, Žarko Bajić, Branka Petrić Miše, Ingrid Belac Lovasić and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The oncologist, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
15.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 170 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. The impact of the COVID-19 pandemic on clinical staging, pathological staging and surgical management of breast cancer patients.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2024
    Article
  8. Article
  9. Article
  10. Breast cancer care amidst a pandemic: a scoping review to understand the impact of coronavirus disease 2019 on health services and health outcomes.International journal for quality in health care : journal of the International Society for Quality in Health Care · 2023
    Article
  11. Article
  12. Article
  13. Impact of Immediate and Delayed Breast Reconstruction on Quality of Life of Breast Cancer Patients.International journal of environmental research and public health · 2022
    Article
  14. Article
  15. Observational
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 1 country.

Eduard VrdoljakDepartment of Oncology, Clinical Hospital Centre Split, School of Medicine, University of Split, Split, Croatia.
Melita Perić BaljaDepartment of Pathology, Clinical Hospital Centre Sisters of Mercy, Zagreb, Croatia.
Zlatko MarušićDepartment of Pathology, Clinical Hospital Centre Zagreb, Zagreb, Croatia.
Manuela AvirovićDepartment of Pathology, Clinical Hospital Centre Rijeka, Rijeka, Croatia.
Valerija BlažičevićDepartment of Pathology, Clinical Hospital Centre Osijek, Osijek, Croatia.
Čedna TomasovićDepartment of Pathology, Clinical Hospital Dubrava, Zagreb, Croatia.
Dora ČerinaDepartment of Oncology, Clinical Hospital Centre Split, School of Medicine, University of Split, Split, Croatia.
Žarko BajićResearch unit "Dr. Mirko Grmek," University Psychiatric Hospital "Sveti Ivan," Zagreb, Croatia.
Branka Petrić MišeDepartment of Oncology, Clinical Hospital Centre Split, School of Medicine, University of Split, Split, Croatia.
Ingrid Belac LovasićDepartment of Oncology, Clinical Hospital Centre Rijeka, Rijeka, Croatia.
Josipa FlamDepartment of Oncology, Clinical Hospital Centre Osijek, Osijek, Croatia.
Snježana TomićDepartment of Pathology, University Hospital of Split, Split, Croatia.
University Hospital Centre Zagreb · HRUniversity of Split · HRKlinički bolnički centar Osijek · HRPsychiatric Hospital Sveti Ivan · HRSisters of Charity Hospital · HRUniversity Hospital Dubrava · HRUniversity of Rijeka · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOur objective was to assess the effects of COVID-19 antiepidemic measures and subsequent changes in the function of the health care system on the number of newly diagnosed breast cancers in the Republic of Croatia. SUBJECTS, MATERIALS, AND

methodsWe performed a retrospective, population- and registry-based study during 2020. The comparator was the number of patients newly diagnosed with breast cancer during 2017, 2018, and 2019. The outcome was the change in number of newly diagnosed breast cancer cases.

resultsThe average monthly percent change after the initial lockdown measures were introduced was -11.0% (95% confidence interval - 22.0% to 1.5%), resulting in a 24% reduction of the newly diagnosed breast cancer cases in Croatia during April, May, and June compared with the same period of 2019. However, during 2020, only 1% fewer new cases were detected than in 2019, or 6% fewer than what would be expected based on the linear trend during 2017-2019.

conclusionIt seems that national health care system measures for controlling the spread of COVID-19 had a detrimental effect on the number of newly diagnosed breast cancer cases in Croatia during the first lockdown. As it is not plausible to expect an epidemiological change to occur at the same time, this may result in later diagnosis, later initiation of treatment, and less favorable outcomes in the future. However, the effect weakened after the first lockdown and COVID-19 control measures were relaxed, and it has not reoccurred during the second COVID-19 wave. Although the COVID-19 lockdown affected the number of newly diagnosed breast cancers, the oncology health care system has shown resilience and compensated for these effects by the end of 2020. IMPLICATIONS FOR PRACTICE: It is possible to compensate for the adverse effects of COVID-19 pandemic control measures on breast cancer diagnosis relatively promptly, and it is of crucial importance to do it as soon as possible. Moreover, as shown by this study's results on the number of newly diagnosed breast cancer cases during the second wave of the pandemic, these adverse effects are preventable to a non-negligible extent.

Indexed as

Breast NeoplasmsCOVID-19Communicable Disease ControlCroatiaFemaleHumansPandemicsRegistriesRetrospective StudiesSARS-CoV-2Breast cancerCoronavirusCOVID-19LockdownPandemicSARS-CoV-2

Identifiers

PMID33856084
PMCPMC8250475
OpenAlexW3156820102

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.